CIK: 0001582384 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 14, 2024
Total Value ($000): $275,541 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | FRONTIER COMMUNICATIONS PARE | 1,412,617 | $34,376 | 12.5% | $22.34 | — | COM | 35909D109 |
| GSHD | GOOSEHEAD INS INC | 516,008 | $34,376 | 12.5% | $62.18 | +22.9% | COM CL A | 38267D109 |
| MCO | MOODYS CORP | 82,208 | $32,310 | 11.7% | $315.11 | +20.6% | COM | 615369105 |
| MSFT | MICROSOFT CORP | 75,000 | $31,554 | 11.5% | $276.41 | +44.4% | COM | 594918104 |
| RLX | RLX TECHNOLOGY INC | 18,046,195 | $30,711 | 11.1% | $4.05 | — | SPONSORED ADS | 74969N103 |
| GLBE | GLOBAL E ONLINE LTD | 801,477 | $29,134 | 10.6% | $25.07 | +47.9% | SHS | M5216V106 |
| DASH | DOORDASH INC | 243,683 | $24,098 | 8.7% | $81.41 | +44.7% | CL A | 25809K105 |
| META | META PLATFORMS INC | 48,814 | $23,703 | 8.6% | $171.20 | +158.9% | CL A | 30303M102 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,920,787 | $7,878 | 2.9% | $24.98 | -83.3% | COM | 019770106 |
| URGN | UROGEN PHARMA LTD | 495,606 | $7,434 | 2.7% | $34.01 | -51.9% | COM | M96088105 |
| — | CONSOLIDATED COMM HLDGS INC | 1,494,447 | $6,456 | 2.3% | $6.02 | — | COM | 209034107 |
| — | SKILLZ INC | 979,848 | $6,359 | 2.3% | $19.79 | — | COM | 83067L109 |
| COIN | COINBASE GLOBAL INC | 17,169 | $4,552 | 1.7% | $109.20 | +64.8% | COM CL A | 19260Q107 |
| — | KRONOS BIO INC | 1,297,959 | $1,687 | 0.6% | $29.87 | — | COM | 50107A104 |
| NMRA | NEUMORA THERAPEUTICS INC. | 54,894 | $755 | 0.3% | $16.17 | 0.0% | COM | 640979100 |
| — | AKILI INC | 545,295 | $158 | 0.1% | $1.12 | — | COMMON STOCK | 00974B107 |